Načítá se...
Differential sleep-promoting effects of dual orexin receptor antagonists and GABA(A) receptor modulators
BACKGROUND: The current standard of care for insomnia includes gamma-aminobutyric acid receptor A (GABA(A)) activators, which promote sleep as well as general central nervous system depression. Dual orexin receptor antagonists (DORAs) represent an alternative mechanism for insomnia treatment that in...
Uloženo v:
| Vydáno v: | BMC Neurosci |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4261741/ https://ncbi.nlm.nih.gov/pubmed/25242351 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2202-15-109 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|